CR10362A - Antagonistas del receptor de vanilloides del subtipo (vr1) y usos de los mismos - Google Patents
Antagonistas del receptor de vanilloides del subtipo (vr1) y usos de los mismosInfo
- Publication number
- CR10362A CR10362A CR10362A CR10362A CR10362A CR 10362 A CR10362 A CR 10362A CR 10362 A CR10362 A CR 10362A CR 10362 A CR10362 A CR 10362A CR 10362 A CR10362 A CR 10362A
- Authority
- CR
- Costa Rica
- Prior art keywords
- subtipo
- antigonists
- vanilloid
- receiver
- same
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4747—Quinolines; Isoquinolines spiro-condensed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/10—Spiro-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
La presente invencion se refiere a compuestos de formula (i) donde las variables X1, X2,Y, R1a,R1b, R2a, R2b, A1, A2, A3 , y A4 son como se definen en la memoria descriptiva, y metodos de uso para tratar dolor, dolor neuropatico, alodinia, dolor asociado con inflamacion o una enfermedad inflamatoria, hiperalgesia inflamatoria, hiperactividad vesical, e incontinencia urinaria.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US79269906P | 2006-04-18 | 2006-04-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
CR10362A true CR10362A (es) | 2008-12-11 |
Family
ID=38610380
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR10362A CR10362A (es) | 2006-04-18 | 2008-10-14 | Antagonistas del receptor de vanilloides del subtipo (vr1) y usos de los mismos |
Country Status (20)
Country | Link |
---|---|
US (2) | US7622493B2 (es) |
EP (1) | EP2012778A4 (es) |
JP (1) | JP2009534399A (es) |
KR (1) | KR20080111144A (es) |
CN (2) | CN102796086A (es) |
AU (1) | AU2007238071B2 (es) |
BR (1) | BRPI0710507A2 (es) |
CA (1) | CA2647256A1 (es) |
CR (1) | CR10362A (es) |
EC (1) | ECSP088888A (es) |
GT (1) | GT200800227A (es) |
MX (1) | MX2008013428A (es) |
MY (1) | MY144307A (es) |
NO (1) | NO20084729L (es) |
NZ (1) | NZ571706A (es) |
RU (1) | RU2450006C2 (es) |
TW (1) | TWI357904B (es) |
UA (1) | UA94940C2 (es) |
WO (1) | WO2007121299A2 (es) |
ZA (1) | ZA200808691B (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR057543A1 (es) * | 2005-10-07 | 2007-12-05 | Glenmark Pharmaceuticals Sa | Derivados de benzofusionado sustituido utilizables como ligandos receptores de vainiloide |
MY144307A (en) * | 2006-04-18 | 2011-08-29 | Abbott Lab | Antagonists of the vanilloid receptor subtype 1 (vr1) and uses thereof |
WO2008110863A1 (en) * | 2007-03-15 | 2008-09-18 | Glenmark Pharmaceuticals S.A. | Indazole derivatives and their use as vanilloid receptor ligands |
WO2009081219A1 (en) * | 2007-12-20 | 2009-07-02 | Glenmark Pharmaceuticals, S.A. | Quinazoline derivatives as vanilloid receptor modulators |
WO2009095726A1 (en) * | 2008-01-29 | 2009-08-06 | Glenmark Pharmaceuticals, S.A. | Acrylamide derivatives as vanilloid receptor 1 modulators |
JP2012505907A (ja) * | 2008-10-17 | 2012-03-08 | アボット・ラボラトリーズ | Trpv1拮抗薬 |
WO2010045402A1 (en) | 2008-10-17 | 2010-04-22 | Abbott Laboratories | Trpv1 antagonists |
JP2013526542A (ja) | 2010-05-12 | 2013-06-24 | アッヴィ・インコーポレイテッド | キナーゼのインダゾール阻害薬 |
JP5934778B2 (ja) | 2011-03-25 | 2016-06-15 | アッヴィ・インコーポレイテッド | Trpv1拮抗薬 |
WO2013096226A1 (en) | 2011-12-19 | 2013-06-27 | Abbvie Inc. | Trpv1 antagonists |
WO2013096223A1 (en) | 2011-12-19 | 2013-06-27 | Abbvie Inc. | Trpv1 antagonists |
US8889730B2 (en) | 2012-04-10 | 2014-11-18 | Pfizer Inc. | Indole and indazole compounds that activate AMPK |
US8796328B2 (en) | 2012-06-20 | 2014-08-05 | Abbvie Inc. | TRPV1 antagonists |
JP6064062B2 (ja) | 2013-03-15 | 2017-01-18 | ファイザー・インク | Ampkを活性化させるインダゾール化合物 |
EP3845532B1 (en) * | 2018-09-30 | 2022-12-21 | Medshine Discovery Inc. | Quinolino-pyrrolidin-2-one derivative and application thereof |
RU2755206C1 (ru) | 2020-05-20 | 2021-09-14 | Федеральное государственное бюджетное учреждение науки Тихоокеанский институт биоорганической химии им. Г.Б. Елякова Дальневосточного отделения Российской академии наук (ТИБОХ ДВО РАН) | Средство пролонгированного анальгетического действия и лекарственный препарат на его основе |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2745305A1 (de) * | 1977-10-07 | 1979-04-19 | Bayer Ag | Insektizide und akarizide mittel |
US5374643A (en) | 1992-09-11 | 1994-12-20 | E. R. Squibb & Sons, Inc. | Aryl urea (thiourea) and cyanoguanidine derivatives |
TW475930B (en) * | 1995-04-24 | 2002-02-11 | Novartis Ag | Novel compound, its use and pharmaceutical composition comprising it |
WO2002020509A2 (de) * | 2000-09-06 | 2002-03-14 | Bayer Aktiengesellschaft | Arzneimittel gegen virale erkrankungen |
DE10120619A1 (de) * | 2001-04-26 | 2002-10-31 | Merck Patent Gmbh | 2-(5-(4-Fluorphenyl)-3-pyridylmethylaminomethyl-chroman |
GB0110901D0 (en) * | 2001-05-02 | 2001-06-27 | Smithkline Beecham Plc | Novel Compounds |
US6821971B2 (en) * | 2001-09-20 | 2004-11-23 | The Procter & Gamble Company | Fused pyrazolone compounds which inhibit the release of inflammatory cytokines |
CA2476936A1 (en) * | 2002-02-20 | 2003-08-28 | Chih-Hung Lee | Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor |
EP1506166B1 (en) | 2002-05-17 | 2011-11-16 | Janssen Pharmaceutica NV | Aminotetralin-derived urea modulators of vanilloid vr1 receptor |
US6933311B2 (en) * | 2003-02-11 | 2005-08-23 | Abbott Laboratories | Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor |
EP1601665A2 (en) | 2003-03-07 | 2005-12-07 | Glaxo Group Limited | Urea derivatives |
ATE411982T1 (de) * | 2003-06-12 | 2008-11-15 | Abbott Lab | Kondensierte verbindungen, die den vanilloid receptor subtype 1 (vr1)-rezeptor hemmen |
EP1589015A1 (en) * | 2004-02-03 | 2005-10-26 | Université de Liège | Benzopyran derivatives, method of production and use thereof |
EP2527339A1 (en) | 2004-11-24 | 2012-11-28 | Abbott Laboratories | Chromanylurea compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor and uses thereof |
US7615570B2 (en) * | 2004-12-13 | 2009-11-10 | Abbott Laboratories | Antagonists to the vanilloid receptor subtype 1 (VR1) and uses thereof |
BRPI0519013A2 (pt) * | 2004-12-13 | 2009-11-03 | Lilly Co Eli | composto ou esteroisÈmeros únicos, misturas de esteroisÈmeros, sais, tautÈmeros ou pró-drogas destes farmaceuticamente aceitáveis, composição farmacêutica, e, uso de um composto |
NZ563200A (en) * | 2005-05-11 | 2011-04-29 | Abbott Lab | Antagonists of the vanilloid receptor subtype 1 (VR1) and uses thereof |
AR057543A1 (es) * | 2005-10-07 | 2007-12-05 | Glenmark Pharmaceuticals Sa | Derivados de benzofusionado sustituido utilizables como ligandos receptores de vainiloide |
CN101321766A (zh) * | 2005-10-07 | 2008-12-10 | 格兰马克药品股份有限公司 | 取代的苯并稠合的衍生物及其作为香草素受体配体的用途 |
RU2008121205A (ru) | 2005-10-28 | 2009-12-10 | Абботт Лаборэтриз (Us) | Производные индазола (варианты), включающая их фармацевтическая композиция и способ лечения или предупреждения заболеваний, чувствительных к ингибированию рецептора trpv1 (варианты) |
MY144307A (en) * | 2006-04-18 | 2011-08-29 | Abbott Lab | Antagonists of the vanilloid receptor subtype 1 (vr1) and uses thereof |
PE20081692A1 (es) * | 2007-01-24 | 2008-12-18 | Mochida Pharm Co Ltd | Nuevo derivado de heterocicliden acetamida |
WO2008110863A1 (en) * | 2007-03-15 | 2008-09-18 | Glenmark Pharmaceuticals S.A. | Indazole derivatives and their use as vanilloid receptor ligands |
-
2007
- 2007-04-12 MY MYPI20084102A patent/MY144307A/en unknown
- 2007-04-12 CN CN2012102446499A patent/CN102796086A/zh active Pending
- 2007-04-12 RU RU2008145506/04A patent/RU2450006C2/ru not_active IP Right Cessation
- 2007-04-12 MX MX2008013428A patent/MX2008013428A/es active IP Right Grant
- 2007-04-12 JP JP2009506693A patent/JP2009534399A/ja active Pending
- 2007-04-12 CN CNA2007800136476A patent/CN101426498A/zh active Pending
- 2007-04-12 NZ NZ571706A patent/NZ571706A/en not_active IP Right Cessation
- 2007-04-12 UA UAA200813308A patent/UA94940C2/ru unknown
- 2007-04-12 KR KR1020087028075A patent/KR20080111144A/ko not_active Application Discontinuation
- 2007-04-12 CA CA002647256A patent/CA2647256A1/en not_active Abandoned
- 2007-04-12 AU AU2007238071A patent/AU2007238071B2/en not_active Ceased
- 2007-04-12 WO PCT/US2007/066515 patent/WO2007121299A2/en active Application Filing
- 2007-04-12 BR BRPI0710507-0A patent/BRPI0710507A2/pt not_active IP Right Cessation
- 2007-04-12 EP EP07760554A patent/EP2012778A4/en not_active Withdrawn
- 2007-04-13 US US11/735,074 patent/US7622493B2/en not_active Expired - Fee Related
- 2007-04-18 TW TW096113670A patent/TWI357904B/zh not_active IP Right Cessation
-
2008
- 2008-10-10 ZA ZA200808691A patent/ZA200808691B/xx unknown
- 2008-10-14 CR CR10362A patent/CR10362A/es not_active Application Discontinuation
- 2008-10-21 GT GT200800227A patent/GT200800227A/es unknown
- 2008-11-10 NO NO20084729A patent/NO20084729L/no not_active Application Discontinuation
- 2008-11-14 EC EC2008008888A patent/ECSP088888A/es unknown
-
2009
- 2009-05-28 US US12/474,035 patent/US8598220B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
WO2007121299A3 (en) | 2008-11-13 |
TWI357904B (en) | 2012-02-11 |
MY144307A (en) | 2011-08-29 |
US20070249614A1 (en) | 2007-10-25 |
MX2008013428A (es) | 2008-11-04 |
BRPI0710507A2 (pt) | 2011-08-16 |
EP2012778A4 (en) | 2011-08-10 |
JP2009534399A (ja) | 2009-09-24 |
AU2007238071A1 (en) | 2007-10-25 |
CA2647256A1 (en) | 2007-10-25 |
ECSP088888A (es) | 2008-12-30 |
UA94940C2 (ru) | 2011-06-25 |
AU2007238071B2 (en) | 2012-06-07 |
WO2007121299A2 (en) | 2007-10-25 |
US8598220B2 (en) | 2013-12-03 |
NO20084729L (no) | 2008-11-10 |
RU2008145506A (ru) | 2010-05-27 |
ZA200808691B (en) | 2010-03-31 |
KR20080111144A (ko) | 2008-12-22 |
NZ571706A (en) | 2012-06-29 |
CN102796086A (zh) | 2012-11-28 |
CN101426498A (zh) | 2009-05-06 |
GT200800227A (es) | 2009-07-09 |
US20090233953A1 (en) | 2009-09-17 |
US7622493B2 (en) | 2009-11-24 |
RU2450006C2 (ru) | 2012-05-10 |
EP2012778A2 (en) | 2009-01-14 |
TW200808808A (en) | 2008-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR10362A (es) | Antagonistas del receptor de vanilloides del subtipo (vr1) y usos de los mismos | |
ECSP099502A (es) | 4-fenil-piran-3,5-dionas, 4-fenil-tiopiran-3,5-dionas y ciclohexantrionas como nuevos herbicidas | |
CL2011002209A1 (es) | Compuestos derivados de 2-mercaptoquinolin-3-carboxamida; medicamento que los comprende; y uso para tratar el dolor, epilepsia, incontinencia urinaria, ansiedad, dependencia manias, transtornos bipolares, migraña, enfermedades cognitivas, discinesia asociada a la distonia y/o incontinencia urinaria. | |
CR11492A (es) | Peptidil nitrilos y uso de los mismos como inhibidores de dipeptidil peptidasa i | |
UY36907A (es) | Nuevas carboxamidas de acción microbiocida | |
CR11517A (es) | Derivados bis-(sulfonilamino) para uso en terapia | |
UY32049A (es) | Inhibidores de cmet | |
CU23778B7 (es) | Pirrolopirazoles, inhibidores potentes de quinasa | |
GT200600035A (es) | Aminopiridinas como inhibidores de beta-secretasa | |
CR8986A (es) | Isoxazoles sustituidos como fungicidas | |
CR20110069A (es) | Agentes de fijacion al receptor notch1 y metodos para el uso de los mismos | |
AR053066A1 (es) | Arabinofuranosidasas | |
CR8357A (es) | Derivados de tetrahidronaftaleno, procedimiento para su preparacion y su uso como antiinflamatorio | |
CR11274A (es) | Anticuerpos anti-cd79b e inmunoconjugados humanizados y metodos de uso | |
PA8657801A1 (es) | Aminalcoholes triciclicos, procedimientos para su preparacion | |
UY30748A1 (es) | Compuesto0s novedosos | |
CR11416A (es) | Algunos derivados de 2-pirazinona y su uso como inhibidores de elastasa de los neutrofilos | |
ECSP11011245A (es) | Novedosos herbicidas | |
PA8618901A1 (es) | Biaril sulfonamidas y metodo para el uso de las mismas | |
ECSP109920A (es) | Herbicidas novedosos | |
HN2009003466A (es) | Herbicidas novedosos | |
CL2020001480A1 (es) | Métodos para obtener células derivadas de músculo. | |
PA8644701A1 (es) | Derivados de alquiliden-tetrahidronaftaleno, procedimiento para su preparacion y su uso como antiinflamatorios | |
UY31449A1 (es) | Propagacion de ortomixoviridae | |
UY32772A (es) | Etilamidas de benzotienilo novedosas y sus usos como microbicidas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal (granting procedure) |